Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression

PURPOSE: Previous sequencing studies revealed that alterations of genes associated with DNA damage response (DDR) are enriched in men with metastatic castration-resistant prostate cancer (mCRPC). BRCA2, a DDR and cancer susceptibility gene, is frequently deleted (homozygous and heterozygous) in men...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Chakraborty, Goutam, Armenia, Joshua, Mazzu, Ying Z., Nandakumar, Subhiksha, Stopsack, Konrad H., Atiq, Mohammad, Komura, Kazumasa, Jehane, Lina E., Hirani, Rahim, Chadalavada, Kalyani, Yoshikawa, Yuki, Khan, Nabeela, Chen, Yu, Abida, Wassim, Mucci, Lorelei A., Lee, Gwo-Shu Mary, Nanjangud, Gouri, Kantoff, Philip W.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7416644/
https://ncbi.nlm.nih.gov/pubmed/31796516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1570
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars